Solid oxide fuel cells (SOFCs) directly convert chemical energy from fuels into electrical energy through electrochemical reactions. SOFCs operate at high temperatures between 600-1800¡ãC using fuels like natural gas, methane or propane. The electrolyte is made of ceramic materials like zirconium and doped perovskite. SOFCs have efficiencies between 45-60% and costs around 2700 INR/KW. They produce clean energy, have modular construction and long lifetimes up to 100,000 hours. Challenges include reducing costs through lower material costs and operating temperatures while increasing power outputs.
Edward Jenner performed the first vaccination in 1796 in England, using cowpox matter to immunize a child against smallpox. His work laid the foundation for modern vaccination. Today, children receive a series of vaccinations for diseases like hepatitis B, diphtheria, and measles between birth and school age. However, some parents choose not to vaccinate due to disproven fears about side effects and links to autism, putting their own and other children's health at risk. While no vaccine is completely without risk, studies show the risks of contracting diseases without vaccination far outweigh any vaccine side effects.
The document discusses childhood immunization schedules and the benefits and risks of immunization versus the risks of diseases. It provides the recommended immunization schedule in the UK and explains that immunizations protect both an individual child's health as well as the health of others by helping to eliminate diseases. While immunizations carry small risks like fever or soreness, the diseases themselves pose much higher risks including death in some cases. The importance of immunization is evidenced by examples of disease outbreaks prior to widespread immunization. The document also discusses the discredited claim by Dr. Wakefield linking the MMR vaccine to autism and common reasons some people oppose immunization despite the lack of evidence that vaccines are dangerous.
This document provides information about immunization and vaccination. It discusses how immunization works to protect the body from infectious diseases through vaccination or exposure to antigens. The document also includes Nigeria's national immunization schedule, which recommends vaccines for diseases like polio, diphtheria, pertussis, and measles at various ages from birth through adolescence. It notes that minor side effects like fever or rashes are normal after some vaccinations. Only high fever or other severe reactions require medical attention.
The document is about children's health care and development by Dr. Abuukar Nuur Xuseyn, a pediatric disease specialist. It discusses vaccination as a right of children and responsibility of parents. It also covers breastfeeding and nurturing, autism, and that every child comes with a message that God has not given up on humanity.
Our top priority is building Banadirland State to give our people peace, prosperity and security. The document argues that XDB is the only party that can achieve this goal.
Safety data generation
? Pre clinical phase ? Clinical phase ? Post approval phase (PMS)
ICH Guidelines for Pharmacovigilance ? Organization and objectives of ICH
? Expedited reporting
? Individual case safety reports ? Periodic safety update reports ? Post approval expedited reporting
? Pharmacovigilance planning
? Good clinical practice in pharmacovigilance studies
EXPLORING THE ROLE OF PROBIOTICS AND POSTBIOTICS IN MODERN MEDICNE.pptxKeerthanaJagan
?
This presentation is all about gut microbiome, discovery of probiotics, Postbiotics, prebiotic. Their definition, comparison, clinical and non clinical application, future perspectives of probiotics and Postbiotics, limitations of probiotics, why Postbiotics is superior to probiotics, advantages of Postbiotics, role in autism, acute pancreatitis, type 1 diabetes mellitus, type 2 diabetes mellitus, clostridium deficile infection, colorectal cancer, NEC in Very low birth weight newborns, VAP, Biological doping, food biofilm removal, anti obesogenic role, immunomodulation, SCFAs, cosmetic applications, hypertension management, gut brain axis, migrain management,
Select background slides from my oral presentation as a Discussant at the oral abstract session for the Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology Track at the ASCO Annual Meeting, May 29, 2025. I reviewed three trials reporting outcomes on ctDNA detection across numerous types of solid tumor malignancies.
Chair and Presenter, Hans Lee, MD, and Jeff Yorio, MD, discuss lymphoma in this CME/MOC/NCPD/AAPA/IPCE activity titled ¡°Planting Roots for Next-Gen Bispecific Antibodies in Hematologic Cancers: Collaborative Principles to Extend the Reach of Immunotherapy in Myeloma and Lymphoma.¡± For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3MVxgqh. CME/MOC/NCPD/AAPA/IPCE credit will be available until May 27, 2026.
Exomind in General Aesthetics - the US Experience.pptxlcadymd1
?
On June 2, 2025, Dr. Cady delivered this lecture to the BTL Hong Kong group for an international audience composed of health care and aesthetic practitioners from multiple countries.
In this presentation, two clinical trials using the Exomind - a novel, state-of-the-art TMS device - were reviewed, as well as Dr. Cady's experience with this device in clinical practice at CWI.
The rationale for the quick onset and significant therapeutic effects of Exomind was reviewed.
This was presented at the Spring Patient Education Conference, held on May 3, 2025, hosted by the Scleroderma Foundation of Greater Chicago in Oak Brook, IL.
??Interstitial lung disease (ILD) is a complication of scleroderma that leads to inflammation and scarring of the lungs. This talk will discuss the clinical presentation, common tests ordered and their results, and treatment for scleroderma-associated interstitial lung disease.
?
Cathryn Lee is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Chicago. Dr. Lee has clinical and research interests in interstitial lung disease. Her research focuses on the relationship between inhalation exposures, both occupational and domestic, and clinical outcomes in patients with interstitial lung disease (ILD). Her current work describes the relationship between exposures and survival across all ILDs regardless of underlying subtype. Her overall goal is to better identify these exposures to both improve outcomes in patients with ILD as well as prevent ILD in those who are at high risk.
To learn more about scleroderma and the foundation, head to www.stopscleroderma.org.
The document is about children's health care and development by Dr. Abuukar Nuur Xuseyn, a pediatric disease specialist. It discusses vaccination as a right of children and responsibility of parents. It also covers breastfeeding and nurturing, autism, and that every child comes with a message that God has not given up on humanity.
Our top priority is building Banadirland State to give our people peace, prosperity and security. The document argues that XDB is the only party that can achieve this goal.
Safety data generation
? Pre clinical phase ? Clinical phase ? Post approval phase (PMS)
ICH Guidelines for Pharmacovigilance ? Organization and objectives of ICH
? Expedited reporting
? Individual case safety reports ? Periodic safety update reports ? Post approval expedited reporting
? Pharmacovigilance planning
? Good clinical practice in pharmacovigilance studies
EXPLORING THE ROLE OF PROBIOTICS AND POSTBIOTICS IN MODERN MEDICNE.pptxKeerthanaJagan
?
This presentation is all about gut microbiome, discovery of probiotics, Postbiotics, prebiotic. Their definition, comparison, clinical and non clinical application, future perspectives of probiotics and Postbiotics, limitations of probiotics, why Postbiotics is superior to probiotics, advantages of Postbiotics, role in autism, acute pancreatitis, type 1 diabetes mellitus, type 2 diabetes mellitus, clostridium deficile infection, colorectal cancer, NEC in Very low birth weight newborns, VAP, Biological doping, food biofilm removal, anti obesogenic role, immunomodulation, SCFAs, cosmetic applications, hypertension management, gut brain axis, migrain management,
Select background slides from my oral presentation as a Discussant at the oral abstract session for the Developmental Therapeutics-Molecularly Targeted Agents and Tumor Biology Track at the ASCO Annual Meeting, May 29, 2025. I reviewed three trials reporting outcomes on ctDNA detection across numerous types of solid tumor malignancies.
Chair and Presenter, Hans Lee, MD, and Jeff Yorio, MD, discuss lymphoma in this CME/MOC/NCPD/AAPA/IPCE activity titled ¡°Planting Roots for Next-Gen Bispecific Antibodies in Hematologic Cancers: Collaborative Principles to Extend the Reach of Immunotherapy in Myeloma and Lymphoma.¡± For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3MVxgqh. CME/MOC/NCPD/AAPA/IPCE credit will be available until May 27, 2026.
Exomind in General Aesthetics - the US Experience.pptxlcadymd1
?
On June 2, 2025, Dr. Cady delivered this lecture to the BTL Hong Kong group for an international audience composed of health care and aesthetic practitioners from multiple countries.
In this presentation, two clinical trials using the Exomind - a novel, state-of-the-art TMS device - were reviewed, as well as Dr. Cady's experience with this device in clinical practice at CWI.
The rationale for the quick onset and significant therapeutic effects of Exomind was reviewed.
This was presented at the Spring Patient Education Conference, held on May 3, 2025, hosted by the Scleroderma Foundation of Greater Chicago in Oak Brook, IL.
??Interstitial lung disease (ILD) is a complication of scleroderma that leads to inflammation and scarring of the lungs. This talk will discuss the clinical presentation, common tests ordered and their results, and treatment for scleroderma-associated interstitial lung disease.
?
Cathryn Lee is an Assistant Professor of Pulmonary and Critical Care Medicine at the University of Chicago. Dr. Lee has clinical and research interests in interstitial lung disease. Her research focuses on the relationship between inhalation exposures, both occupational and domestic, and clinical outcomes in patients with interstitial lung disease (ILD). Her current work describes the relationship between exposures and survival across all ILDs regardless of underlying subtype. Her overall goal is to better identify these exposures to both improve outcomes in patients with ILD as well as prevent ILD in those who are at high risk.
To learn more about scleroderma and the foundation, head to www.stopscleroderma.org.
Patient with Cancer Neoplasia ¨C Pathophysiology Notes
Description:
This ºÝºÝߣShare presentation provides a detailed overview of the pathophysiology of cancer neoplasia. It is designed for nursing and healthcare students seeking to understand the mechanisms behind abnormal cell growth, tumor formation, and the progression of malignant neoplasms. Key topics include:
Definition and classification of neoplasia
Cellular changes in cancer
Mechanisms of carcinogenesis
Tumor markers and lab investigations
Clinical manifestations
Nursing and medical management principles
These notes are ideal for academic revision, classroom teaching, or exam preparation.
Communication in pharmacovigilance ? Effective communication in Pharmacovigilance ? Communication in Drug Safety Crisis management ? Communicating with Regulatory Agencies, Business Partners, Healthcare facilities &
Media
1. DARYEELKA CAAFIMAADKA
HOOYADA IYO DHALAANKA
DOTT. Abuukar Nuur Xuseyn
Takhtarka Cudurrada Caruurta
¡°BUUGGA JADEECADA¡±
Talaalku waa xaq ay leeyihiin caruurta waana waajib saaran waalidiinta
¡°Every death due to measles could be prevented
with a simple vaccination that costs less than a dollar per child.¡±
2. JADEECO
Jadeecadu waxay ka mid ah cudurrada Soomaalida ay ku tilmaami jirtay Lixda
Cuduro ee Dilaagaa ah, kuwaas oo ka jira Dalkeena Soomaaliya.
Somaliya waxa ay ka mid tahay dalalka saboolka ah oo aan gaarin isku filnaansho
dhaqaale ay ku daryeeli karto caafimaadka bulshada waxaana waddanka oo gabi
ahaan ka jirin siyaasad iyo barnaamijyo lagu hormariyo caafimaadka bulshada guud
ahaan gaar ahaana midda caruurta iyo hooyada taasoo keentay in kumanaan caruur
iyo hooyooyin aan la talaalin ay u geeriyodaan ama ay u naafoobaan cudurka
jadeecada iyo cudurada kale ee la midka ahi.
Jadeecada waa cudur ba'an oo si dhaqsi ah bulshada ugu faa'fo, waxaa keena fiirus oo
ka tirsan qoyska Paramixovirus nooca Morbillivirus.
Jadeecada meel kasta ee aduunka ayee ka dillaaci kartaa hase ahaatee wadamada
horay u hormaray waxay ku dadaaleen kuna gulaysteen in Cudurkaani ay ka
badbaadiyaan caruurta iyo dhamaan bulshada taasoo u suuro gelisay adeegsiga
balaaran ee Talaalka.
Daraasad la sameeyay sanadku markuu ahaa 1997 waxaa lagu soo bandhigay in
Jadeecada ay saamaysay 31 milyan qof oo 1milyan qof u geeriyootay, milyankaas
qofood ee u dhimatay Jadeecada kala bar (500.000) waxay ka soo jedeen Qaaradda
Afrika (Africa sub-saharan).
Daraasad kale ee WHO samaysay waxay qiyaastay sanadkii 2001 in 30-40 milyan
qof uu cudurka Jadeecada saameeyay, 750,000 ilaa 1 milyana ay u geeriyodeen.
Wadamada ay Jadeecadu ku badan tahay (Endemic area) waqti kasto ayuu ka dilaaci
kartaa siiba xilliyada dugsiyada ay furan yihiin.
Afartii sano Jadeecada marbay si balaaran u faaftaa (measles outbreak),oo ay si ba'an
u saameesaa caruurta.
Sanadkii hore 2014 cudurka Jadeecada si balaaran ayuu ugu faafay Soomaaliya
(measles outbreak):
FURUURUCA JADEECADA
3. Bayaanka ay si wadajir u soo saareen WHO iyo Unicef ayaa lagu qeexayaa culayska
uu leeyahay cudurka Jadeecada iyo dhibaatada uu caruurta u gaysan karo:
¡° The infection rate - according to the latest figures - is four times higher than the average recorded
in the same period of 2013, while a vaccination campaign should be carried out urgently, to stop
thousands of preventable deaths, "they said UNICEF and WHO (World Organisation health) in a
joint statement."We have a very large number of Somali children malnourished," said the head of
UNICEF in Somalia Sikander Khan.¡±
"The malnourished children can get sick more easily and are more likely to die or remain disabled
for life, such as losing your sight, hearing or bringing damage to the brain, as a result of measles,"
said the head of WHO in Somalia, Ghulam Popal, stressing that the epidemic is "extremely
worrying", with 10% of infected children who are likely to die from complications.
In recent months, about half a million Somali children have been vaccinated, but are at least five
million in total - according to the UN - those in need of protection. In some areas of the country on
the Horn of Africa, particularly in the south and central regions, including areas where African
Union troops are battling Islamic fundamentalists Shebab - immunization rates are just 15%.
Less than a third of children under one year of age were vaccinated throughout the country in 2013.
450,000 children die each year (one child every minute) due to this disease in the African continent
so that measles causes more deaths among African children that HIV, Tuberculosis and Malaria.
Every death due to measles could be prevented with a simple vaccination that costs less than a
dollar per child.
Unicef, Red Cross, ONU, USA have created long-term campaign with the aim to vaccinate 200
million children at risk throughout Africa (This will prevent 1.2 million deaths).
450,000 children die each year (one child every minute) due to this disease in the African continent,
that measles causes more deaths among African children, that HIV, Tuberculosis and Malaria.
Every death due to measles could be prevented with a simple vaccination that costs less than a
dollar per child
UNICEF, the Red Cross, UN and US have created long-term campaign with the aim to vaccinate
200.milioni of children at risk throughout Africa.
(This will prevent 1.2 million deaths.)
4. Cudurrada faafa Jadeecadda waa midka ugu dhaqsiyaha badan ee bulshada ku faafa, ka mid ah
kuwooda ugu dhimashada badan iyo kuwooda ku reebo waxyeelada culus.
Bulshada waxay ku kala qaadaa ama isugu gudbisaa cudurka Jadeecadda hawada, qofka
Jadeecadda qabto wuxuu firuska bulashada ugu gudbiyaa goortoo hadlayaa, ama qoslaaya, ama
hindhisaya., ama qufucaya.
Sida lagu garto cudurka Jadeecadda waa mid aad u adag xilliyada hore goortuu firuska ku tarmaya
jirka gudahiisa oo aana jirin wax astaamo ah oo lala xiriirin karo, 12-14 maalmood ka dib ayaa la
tuhmi karaa cudurka Jadeecadda goortay soo ifbaxaan aastaama ugu horeeya kuwaaso ah:
1) Qandho
2) Indho xanuun iyo indho cun-cun
3) hergab
4) afka gudahiisa oo dhibo cad lagu arko (Koplik spots).
5) Dhuun xanuun
6) Qufac daran.
4-5 maalmood ka dib aya jirkoo idil furuuruc ka soo baxaya, furuurucan ayaa wehliyo cun-cun
xilligan ayaa la xaqiijin karaa in cudurka uu yahay Jadeeco.
Xilliga boogsashada ayaa soo hagaagaya maalinba maalinta ka dambayso caafimaadka bukaanka
haseyeeshee waa xilligani goortay soo ifbaxayaan dhibaatooyinka uu qofka ku reebi karo, siiba
caruurta da'dooda ka hoosayso 5 sano ayee soo gaartaa dhibaatooyinka culus.
Furuuruxa Jadeecada
Koplik spots
5. Way adag tahay in caruurta ilaa sanad jirka lagu arko Cudurka Jadeecada haddii Hooyada uurka ka
hor uu ku dhacay Jadeeco amaba laga talaalay.
Waxaan og nahay in Hooyada xilliga uurka ay u gudbiso cunuga unugyada ka hortagga cudurka
Jadeecada unugyadaasi oo ilaa muddo sanad ah ka difaacaya cunugga Jadeecada.
Haddana waxaa suuro gal ah in Jadeecada ee saameeso caruurta da'dooda aad u yar bil ilaa sanad.
Ilaa iyo iminka ayaa la xaqiijiyay in 4 caruur oo da'dooda ka hoosayso sanad ay Jadeecadu
haleeshay.
1) 1 Cunug oo 4 bilood jira
2) 2 Cunug oo 7 bilood jira
3) 1 Cunug oo 11 bilood jira
Dhacdadaani waxaa loo asbaabeeyay in:
a) In Hooyada aysan qaadan talaalka ka hortagga cudurka Jadeecada.
b) In Hooyada uusan ku dhicin cudurka Jadeecada.
c) In ay jirto nafaqa darro.
Haddii Hooyada ay qaado Cudurka Jadeecada xilliga uurka waxaa suuro gal ah in cunuga uu
dhicisoobo ama uu uurka ku dhinto.
Dhibaatooyinka la xiriira Cudurka Jadeecadda:
1) Dhaga xanuu ama fasaska dhagaha ama maqal la'aan.
2) Pneuumonia
3) Encephalitis waa dhibaatada ugu halista badan oo ka mas'uul noqon karto
naafo, qalal, maqal la'aan, arag la'aan iyo dhimasho.
Saadasha (Prognosis):
Saadaasha cudurka Jadeecadda maaha mid xun maaadaama waqtiyadii ugu
dambeeyay uu sare u kacay isticmaalka antibiotiga ka hortaga dhibaatooyinka la
xiriira fasasyada bacterialka.
Badi dhimashada waxay la xiriirta Encephalitis.
Saadashada ma wanaagsana dadka difaaca jirkooda hoos u dhacsanyahay (immuno-
deficiency) iyo caruurta nafaqa darrada haysato.
6. Daaweenta Cudurka Jadeecadda:
Ma jirto daawo u qaas ah Cudurka Jadeecadda.
Hase ahaatee waxaa laga maarmaan noqon karo isticmaalka antibiyootigo goortay
soo if baxaan dhibaatooyinka la xiriira Jadeecadda.
Fitamiin A qaadashadeeda ayaa la xaqiijiyay in ay u wanaagsantahay dadka ku dhaca
Cudurka Jadeecada qaasatan caruurta da'dooda ka hoosaysa 2 sano iyo kuwa nafaqa
darrada haysato.
Jadeecadu Daawo ma laha.
MACLUUMAADKA DHIMASHADA:
Wadamada reer galbeedka iyo kuwa hor'umarka ku dhaqaaqay ayaa aad ugu yar faafidda cudurka
jadeecada iyo dhimashada la xiriirto maadaama ay wadamadaani ay si balaaran u adeegsadeen
talaalka MMRka.
Wadamada Saboolka qaasatan kuwa Qaaradda Afrika dhimashada la xiriirta cudurka Jadeecadda
waxaa lagu qiyaasay 30% taasoo u sabab ah adeegsi la'aanta talaalka MMRka ama adeegsiga
talaalka MMRka uusan gaarsiisneen heerkii loo baahnaa.
Faafidda cudurka Jadeecadda ayaa maanta ah halista ugu weyn ee nolosha dadka, gaar ahaan
carruurta kuwooda nafaqa darrada haysata iyo caruurta ay ku yartahay fitamiin A.
Waxaa la qiyaasay in cudurka Jadeecadda uu meesha afaraad kaga jiro 10ka sababood ugu
muhiimsan ee loo dhinto.
Midda kale Jadeecadda waxay ka mid tahay cudurrada indhala'aan ku ridda caruurta.
7. Talaalka MMR iyo Autismka:
Dhoowr jeer ayaan la kulmay waalidiin badan ee soomaaliyeed ka cabsi qaba in ay caruurtooda ka
talaalaan Cudurka Jadeecada ama gebi ahaanba diidan talaalaka MMRka, iyagoo ka muuqatay wel-
wel xoogan ee la xiriira dhibaatada uu lahaan karo talaalka MMRka ama shakiga ay ka qabaan in uu
Talaalkaasi mas'uul ka noqon karo cudurka Autismka ama uu jiro wax xiriir ahi u dhaxeeyo MMR
iyo Autismka.
Waxaan kaloo la kulmay waalidiin Soomaaliyeed leh caruur Autismka qaba oo aaminsan in
Talaalku MMRka uu u sabab yahay Autismka caruurtooda.
Run ahaantii wel-welka iyo cabsida ka muuqato waalidiinta Soomaaliyeed waa dareen ay la
wadaagaan walidiin kale ee wadama kale kasoo jeeda gaar aahaan wadamada Reer Galbeedka.
Waa su'aal mar marwalba soo noq-noqoto una baahan in jawaab sax ah laga bixiyo oo ay
waalidiinta Soomaaliyeed ku qanci karaan inkastoo mar hore culumada saaniska xaqiijiyeen in
uusan jirin wax dhibaato uu leeyahay Talaalka MMRka uusana ka mas'uul ahayn Autismka.
Wargayska caafimaad ee loo yaqaano Lancet ayaa lagu soo daabacay 1998 maqaal uu qoray
dhakhtar Ingiriis ah Andrew Wakefield isagoo ku doodayo in tallaalku MMRku uu sabab u yahay
cudurada xiidmaha ee la xiriira Kanner Sindrome (Autism Spectrum Disorder).
Maqaalka Wakefield wuxuu dhaliyay dood cilmiyeed balaaran oo muddo dheer socotay ku dhawaad
12 sano.
Wakefield dhab ahaantii doodiisa ma ahayn mid si rasmi ah u muujinaysay in talaalka MMRka uu
ka mas'uul yahay Kanner Sindrome haddana meelo badan ee doodiisa mugdi ahayd ayuu ifi
waayay.
Nasiibdarro Mr.Wakefield doodiisa aan sal cilmiyeed ku fadhin waxay sababtay in hoos u dhac
balaaran ku yimaada tirada adeegsiga talaalka ka hortagga cudurka Jadeecada ee dalka Mareekanka,
Ingiriiska iyo wadamo kale ee Europe, hoos u dhacaa oo sabab u noqday kiisas farabadan oo
dhibaatooyin xambaarsan oo ay ka mid yihiin Encephalilitis iyo dhimasho.
Guddiga anshaxa ee General British Medical, ka dib markii baaritaan taxadir uu sameeyay, ayuu
natiijo culus ka soo saaray sida Wakefield uu u soo bandhigay baaritaan aan daacad ahayn oo
waxyeelo culus ugaysatay caruur badan qaarkoodna ku naf waayay.
Warbixinta Guddiga Sayniska waxay sii sheegtay in Wakefield uu hoos u dhac balaaran u gaystay
sumcadda Caafimaadka.
Wakefield naftiisa waxaa laga cayriyay Royal College ee Takhaatiirta oo aan mar dambe u shaqayn
Karin.
8. TALAALKA JADEECADA :
Ujeeedada laga leeyahay in caruurta laga talaalka cudurka Jadeecada waa:
1. In cunuga laga difaaco dhibaatooyinka culus uu wato cudurka Jadeecada, kuna
reebi karo.
2. In cunuga jirkiisu uu lahaadaa difaac joogta ah.
3. In la xakameeyo in Jadeecadu ay ku faafto bulshada.
Talaalka loogu talagalay ka hortagga cudurka Jadeecada waa talaal ka samaysan
fiiruska jadeecada oo nool laakin awoodiisa hoos loo dhigay, farsamadaan waxay
suro gelisay in difaaca jirka uu sare u kaco islamarkaana uu awood u yeesho
xakameenta cudurka.
Waxaa jira 3 nooc ee Talaalka Jadeecada:
a) Nooca Schwarz
b) Nooca Moraten
c) Nooca Edmonston-Zagreb.
Inkastoo Talaalka Jadeecada kaligii la adeegsan karo, haddana waxaa caadi ah in
in Cudurrada jadeecada, Qaamooqashiirka iyo Jadeeco Jarmalka hal mar laysla wada
qaato iyagoo loo adeegsanayo Talaalka MMR.
WAQTIGA TALAALKA:
Waa muhiim in caruurta laba jeer ma seddax jeer la Talaala:
1) Goorta cunugu uu da'diisu yahay (wareegtada 1aad) 12-15 bilood
2) Goorta cunuga uu da'diisu yahay (wareegtada 2aad) 4-6 sano
Jadwalkaan waa kan ay adeegsadaan wadama horay u hor'maray, kuwa saboolka ah
ama wadamada soo koraya marxaladaha jira owgeed ayuu jadwalka talaalka ugu
duwan yahay, wadamadaani waxay isticmaalaan jadwal ay ka soo shaqaysay WHO.
1) Wareegtada 1aad markuu cunuga jirsado 6 bilood.
2) Wareegtada 2aad markuu cunuga jirsadu 12-15 bilood.
3) Wareegtada 3aad markuu cunuga jirsado 4-6 sano.
4) Soo qabo oo talaal (Catch up) 4-6 ; 11-12 sano.
9. FIIRO GAAR:
Waxaa suuro gal ah in 5% caruurta la talaalay in jirkooda uusan jawaab ka bixin.
(No responder.)
TALAALKA DADKA WAAWEYN:
Dadka da'dooda ka sareesa 18 sano oo aan weligood qaadan Talaalka MMRka ama
uusan cudarka ku dhicin waa in ay mar qura istilaalan.
Dumarka ku jira xilliga Uurka waxaa talo ah oo wanaagsan in talaalka jadeecada ama
talaalkasto ka sameesan jeermi nool oo awoodiisa hoos loo dhigay in laga ilaaliyo
waayo waxaa suuro gal ah in uu dhibaateeyo cunuga uurka ku jiro.
DHAMAAD.